Vault-13

SAMSARA BIOCAPITAL, LLC

PALO ALTO, CA · CIK 1744967 · 13F filing filed 2022-08-15

SEC-registered investment adviser since 2018 · limited liability company

As an employer

US visa salary filings

Job titleFilingsMedianRange
Senior AssociatePalo Alto, CA 2 $187,500 $175,000 – $200,000

Source: US Department of Labor, Labor Condition Application disclosure data (certified, full-time, yearly equivalent). These are the salaries the employer committed to pay the visa roles it filed for, at least the prevailing wage for the job and place; they are not the pay of all its staff. Filed by: Samsara BioCapital, LLC.

$373.9m reported value -5.4% vs Q1 2022
56positions
64.8%in top 10
5 new 7 added 14 reduced 5 sold out vs Q1 2022

Options: 1 call positions ($1.2m notional), 0 put positions (— notional) – listed below, not included above.

Holdings, Q2 2022

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CHINOOK THERAPEUTICS INC COM ADRO ADRO 5,161,888 $90.3m24.14% 24.14% AddedShares held: Q3 2021 3.4m, Q4 2021 4.6m, Q1 2022 4.6m, Q2 2022 5.2m +570.0k +570,000 12.4%
2 NKARTA INC COM NKTX NKTX 2,868,035 $35.3m9.45% 9.45% AddedShares held: Q3 2021 2.0m, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 2.9m +833.3k +833,333 41.0%
3 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 4,598,828 $25.2m6.75% 6.75% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 339.6k, Q2 2022 4.6m +4.3m +4,259,217 1254.2%
4 GRAPHITE BIO INC COM GRPH GRPH 8,459,314 $23.3m6.22% 6.22% AddedShares held: Q3 2021 7.4m, Q4 2021 7.9m, Q1 2022 8.1m, Q2 2022 8.5m +386.7k +386,711 4.8%
5 ARCELLX INC COMMON STOCK ACLX ACLX 1,063,835 $19.2m5.14% 5.14% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 999.7k, Q2 2022 1.1m +64.1k +64,108 6.4%
6 FORMA THERAPEUTICS HLDGS INC SHS SHS 1,565,526 $10.8m2.88% 2.88% UnchangedShares held: Q3 2021 1.6m, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m
7 LYRA THERAPEUTICS INC COM LYRA LYRA 1,777,251 $10.0m2.69% 2.69% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 1.8m
8 ACLARIS THERAPEUTICS INC COM ACRS ACRS 696,171 $9.7m2.60% 2.60% ReducedShares held: Q3 2021 794.2k, Q4 2021 794.2k, Q1 2022 794.2k, Q2 2022 696.2k -98.0k -98,000 -12.3%
9 IVERIC BIO INC COM OPHT OPHT 1,010,051 $9.7m2.60% 2.60% ReducedShares held: Q3 2021 1.5m, Q4 2021 1.3m, Q1 2022 1.3m, Q2 2022 1.0m -252.5k -252,500 -20.0%
10 INTERCEPT PHARMACEUTICALS IN COM ICPT ICPT 640,688 $8.8m2.37% 2.37% UnchangedShares held: Q3 2021 640.7k, Q4 2021 640.7k, Q1 2022 640.7k, Q2 2022 640.7k
11 SUTRO BIOPHARMA INC COM COM 1,675,579 $8.7m2.33% 2.33% UnchangedShares held: Q3 2021 1.7m, Q4 2021 1.7m, Q1 2022 1.7m, Q2 2022 1.7m
12 RAIN ONCOLOGY INC COM COM 1,560,652 $8.7m2.32% 2.32% ReducedShares held: Q3 2021 1.6m, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m -10.7k -10,727 -0.7%
13 HILLEVAX INC COM COM 762,577 $8.3m2.23% 2.23% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 762.6k
14 INSTIL BIO INC COM COM 1,788,280 $8.3m2.21% 2.21% ReducedShares held: Q3 2021 2.1m, Q4 2021 2.0m, Q1 2022 2.0m, Q2 2022 1.8m -203.7k -203,670 -10.2%
15 CENTESSA PHARMACEUTICALS PLC SPONSORED ADS SPONSORED ADS 1,693,736 $8.2m2.21% 2.21% ReducedShares held: Q3 2021 1.5m, Q4 2021 1.5m, Q1 2022 1.9m, Q2 2022 1.7m -190.4k -190,360 -10.1%
16 PEPGEN INC COM PEPG PEPG 651,050 $6.5m1.73% 1.73% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 651.0k
17 IMMUNOCORE HLDGS PLC ADS IMCR IMCR 160,963 $6.0m1.61% 1.61% UnchangedShares held: Q3 2021 64.0k, Q4 2021 64.0k, Q1 2022 161.0k, Q2 2022 161.0k
18 ZYMEWORKS INC COM ZYME ZYME 970,987 $5.1m1.38% 1.38% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 971.0k, Q2 2022 971.0k
19 JIYA ACQUISITION CORP COM CL A COM CL A 507,041 $5.0m1.34% 1.34% UnchangedShares held: Q3 2021 507.0k, Q4 2021 507.0k, Q1 2022 507.0k, Q2 2022 507.0k
20 IO BIOTECH INC COM IOBTQ IOBTQ 1,008,437 $4.7m1.26% 1.26% ReducedShares held: Q3 2021 0, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.0m -112.0k -112,000 -10.0%
21 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 1,111,112 $4.7m1.25% 1.25% UnchangedShares held: Q3 2021 1.1m, Q4 2021 1.1m, Q1 2022 1.1m, Q2 2022 1.1m
22 JANUX THERAPEUTICS INC COM JANX JANX 360,414 $4.4m1.18% 1.18% ReducedShares held: Q3 2021 411.9k, Q4 2021 411.9k, Q1 2022 411.9k, Q2 2022 360.4k -51.5k -51,457 -12.5%
23 DICE THERAPEUTICS INC COM COM 253,466 $3.9m1.05% 1.05% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 228.5k, Q2 2022 253.5k +25.0k +25,000 10.9%
24 EYEPOINT PHARMACEUTICALS INC COM NEW EYPT EYPT 480,000 $3.8m1.01% 1.01% UnchangedShares held: Q3 2021 450.0k, Q4 2021 480.0k, Q1 2022 480.0k, Q2 2022 480.0k
25 DAY ONE BIOPHARMACEUTICALS I COM COM 196,425 $3.5m0.94% 0.94% ReducedShares held: Q3 2021 202.5k, Q4 2021 202.5k, Q1 2022 202.5k, Q2 2022 196.4k -6.1k -6,075 -3.0%
26 DECIBEL THERAPEUTICS INC COM COM 801,629 $3.4m0.90% 0.90% ReducedShares held: Q3 2021 826.4k, Q4 2021 826.4k, Q1 2022 826.4k, Q2 2022 801.6k -24.8k -24,793 -3.0%
27 BCLS ACQUISITION CORP COM CL A COM CL A 300,000 $3.0m0.79% 0.79% UnchangedShares held: Q3 2021 300.0k, Q4 2021 300.0k, Q1 2022 300.0k, Q2 2022 300.0k
28 TANGO THERAPEUTICS INC COM TNGX TNGX 630,000 $2.9m0.76% 0.76% UnchangedShares held: Q3 2021 700.0k, Q4 2021 630.0k, Q1 2022 630.0k, Q2 2022 630.0k
29 IGM BIOSCIENCES INC COM IGMS IGMS 154,664 $2.8m0.75% 0.75% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 154.7k, Q2 2022 154.7k
30 VIRACTA THERAPEUTICS INC COM SNSS SNSS 689,709 $2.7m0.72% 0.72% ReducedShares held: Q3 2021 711.0k, Q4 2021 711.0k, Q1 2022 711.0k, Q2 2022 689.7k -21.3k -21,330 -3.0%
31 RECURSION PHARMACEUTICALS IN CL A RXRX RXRX 267,996 $2.2m0.58% 0.58% ReducedShares held: Q3 2021 752.9k, Q4 2021 539.2k, Q1 2022 539.2k, Q2 2022 268.0k -271.2k -271,240 -50.3%
32 BOLT BIOTHERAPEUTICS INC COM COM 1,049,153 $2.1m0.57% 0.57% UnchangedShares held: Q3 2021 737.5k, Q4 2021 737.5k, Q1 2022 1.0m, Q2 2022 1.0m
33 AMRYT PHARMA PLC SPONSORED ADS SPONSORED ADS 304,715 $2.1m0.57% 0.57% AddedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 279.7k, Q2 2022 304.7k +25.0k +25,000 8.9%
34 ALX ONCOLOGY HLDGS INC COM ALXO ALXO 262,786 $2.1m0.57% 0.57% UnchangedShares held: Q3 2021 0, Q4 2021 0, Q1 2022 262.8k, Q2 2022 262.8k
35 ALBIREO PHARMA INC COM BIOD BIOD 100,000 $2.0m0.53% 0.53% UnchangedShares held: Q3 2021 100.0k, Q4 2021 100.0k, Q1 2022 100.0k, Q2 2022 100.0k
36 SYROS PHARMACEUTICALS INC COM SYRS SYRS 1,899,616 $1.8m0.49% 0.49% UnchangedShares held: Q3 2021 2.2m, Q4 2021 2.2m, Q1 2022 1.9m, Q2 2022 1.9m
37 SCIENCE 37 HOLDINGS INC COM COM 900,000 $1.8m0.48% 0.48% UnchangedShares held: Q3 2021 0, Q4 2021 900.0k, Q1 2022 900.0k, Q2 2022 900.0k
38 AVADEL PHARMACEUTICALS PLC SPONSORED ADR SPONSORED ADR 659,409 $1.6m0.43% 0.43% UnchangedShares held: Q3 2021 549.2k, Q4 2021 659.4k, Q1 2022 659.4k, Q2 2022 659.4k
39 RHYTHM PHARMACEUTICALS INC COM RYTM RYTM 345,293 $1.4m0.38% 0.38% UnchangedShares held: Q3 2021 300.3k, Q4 2021 345.3k, Q1 2022 345.3k, Q2 2022 345.3k
40 EQUILLIUM INC COM EQ EQ 615,541 $1.3m0.34% 0.34% UnchangedShares held: Q3 2021 738.2k, Q4 2021 615.5k, Q1 2022 615.5k, Q2 2022 615.5k
41 VTV THERAPEUTICS INC CL A VTVT VTVT 1,635,509 $1.2m0.33% 0.33% UnchangedShares held: Q3 2021 0, Q4 2021 1.6m, Q1 2022 1.6m, Q2 2022 1.6m
42 ELEVATION ONCOLOGY INC COM COM 830,565 $1.2m0.31% 0.31% ReducedShares held: Q3 2021 932.2k, Q4 2021 932.2k, Q1 2022 932.2k, Q2 2022 830.6k -101.7k -101,675 -10.9%
43 NOVAVAX INC COM NEW NVAX NVAX 21,244 $1.1m0.29% 0.29% ReducedShares held: Q3 2021 30.2k, Q4 2021 27.1k, Q1 2022 27.1k, Q2 2022 21.2k -5.9k -5,900 -21.7%
44 SURROZEN INC COM COM 300,000 $900.0k0.24% 0.24% UnchangedShares held: Q3 2021 300.0k, Q4 2021 300.0k, Q1 2022 300.0k, Q2 2022 300.0k
45 TERNS PHARMACEUTICALS INC COM COM 289,068 $717.0k0.19% 0.19% UnchangedShares held: Q3 2021 289.1k, Q4 2021 289.1k, Q1 2022 289.1k, Q2 2022 289.1k
46 ATRECA INC CL A COM BCEL BCEL 396,835 $710.0k0.19% 0.19% UnchangedShares held: Q3 2021 396.8k, Q4 2021 396.8k, Q1 2022 396.8k, Q2 2022 396.8k
47 SPRINGWORKS THERAPEUTICS INC COM SWTX SWTX 22,204 $547.0k0.15% 0.15% ReducedShares held: Q3 2021 169.9k, Q4 2021 140.3k, Q1 2022 59.2k, Q2 2022 22.2k -37.0k -37,000 -62.5%
48 ALLAKOS INC COM ALLKG ALLKG 172,089 $539.0k0.14% 0.14% UnchangedShares held: Q3 2021 172.1k, Q4 2021 172.1k, Q1 2022 172.1k, Q2 2022 172.1k
49 AEGLEA BIOTHERAPEUTICS INC COM AGLE AGLE 883,720 $446.0k0.12% 0.12% UnchangedShares held: Q3 2021 883.7k, Q4 2021 883.7k, Q1 2022 883.7k, Q2 2022 883.7k
50 ALLOVIR INC COM COM 82,336 $321.0k0.09% 0.09% UnchangedShares held: Q3 2021 82.3k, Q4 2021 82.3k, Q1 2022 82.3k, Q2 2022 82.3k
51 KRONOS BIO INC COM KRON KRON 78,131 $284.0k0.08% 0.08% UnchangedShares held: Q3 2021 78.1k, Q4 2021 78.1k, Q1 2022 78.1k, Q2 2022 78.1k
52 KALA PHARMACEUTICALS INC COM COM 601,162 $180.0k0.05% 0.05% UnchangedShares held: Q3 2021 601.2k, Q4 2021 601.2k, Q1 2022 601.2k, Q2 2022 601.2k
53 NGM BIOPHARMACEUTICALS INC COM NGM NGM 13,669 $175.0k0.05% 0.05% UnchangedShares held: Q3 2021 13.7k, Q4 2021 13.7k, Q1 2022 13.7k, Q2 2022 13.7k
54 ASTRIA THERAPEUTICS INC COM CATB CATB 25,000 $75.0k0.02% 0.02% UnchangedShares held: Q3 2021 25.0k, Q4 2021 25.0k, Q1 2022 25.0k, Q2 2022 25.0k
55 NUVATION BIO INC *W EXP 07/07/202 NUVB.WS NUVB.WS 133,333 $37.0k0.01% 0.01% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 133.3k
56 SURROZEN INC *W EXP 08/01/203 *W EXP 08/01/203 99,999 $19.0k0.01% 0.01% NewShares held: Q3 2021 0, Q4 2021 0, Q1 2022 0, Q2 2022 100.0k

Sold out since Q1 2022

SecurityTickerShares held beforeValue then
ODONATE THERAPEUTICS INC 700,421 $925.0k700.4k shares
BIONTECH SE BNTX BNTX 4,031 $688.0k4.0k shares
ROCKET PHARMACEUTICALS INC RCKT RCKT 40,550 $643.0k40.5k shares
VISTAGEN THERAPEUTICS INC VTGN VTGN 488,632 $606.0k488.6k shares
AMARIN CORP PLC 25,000 $82.0k25.0k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
NOVAVAX INC NVAX · Call NVAXCall 23,400 $1.2m23.4k shares Unchanged